ONLINE DATABASE SEARCH - OI-LS-301-MEMO
1. 43797 OI-LS-301; PUBMED-OI-7/26/2004
Effect of silver-carrying photocatalyst "hikari-gintech" on mycobacterial growth in vitro
Matsui, Y, Otomo, K, Ishida, S, Yanagihara, K, Kawanobe, Y, Kida, S, Taruoka, E, and Sugawara, I
Microbiol Immunol 2004. 48(7): 489-95
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15272193&dopt=abstract
2. 43798 OI-LS-301; SCIFINDER-OI-7/21/2004
In vitro effects of resveratrol on the viability and infectivity of the microsporidian Encephalitozoon cuniculi
Leiro, Jose, Cano, Ernesto, Ubeira, Florencio M, Orallo, Francisco, and Sanmartin, Manuel L
Antimicrobial Agents and Chemotherapy 2004. 48(7): 2497-2501
3. 43799 OI-LS-301; PUBMED-OI-7/26/2004
5th antiviral drug discovery & development summit
Blair, W and Perros, M
Expert Opin Investig Drugs 2004. 13(8): 1065-9
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15268642&dopt=abstract
4. 43800 OI-LS-301; SCIFINDER-OI-7/21/2004
Polyamine metabolism in a member of the phylum Microspora (Encephalitozoon cuniculi): Effects of polyamine analogues
Bacchi, Cyrus J, Rattendi, Donna, Faciane, Evangeline, Yarlett, Nigel, Weiss, Louis M, Frydman, Benjamin, Woster, Patrick, Wei, Benjamin, Marton, Laurence J, and Wittner, Murray
Microbiology (Reading, United Kingdom) 2004. 150(5): 1215-1224
5. 43801 OI-LS-301; PUBMED-OI-7/26/2004
Recent developments in target identification against hepatitis C virus
Brass, V, Blum, HE, and Moradpour, D
Expert Opin Ther Targets 2004. 8(4): 295-307
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15268625&dopt=abstract
6. 43802 OI-LS-301; PUBMED-OI-7/26/2004
Ribozymes in the age of molecular therapeutics
Bagheri, S and Kashani-Sabet, M
Curr Mol Med 2004. 4(5): 489-506
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15267221&dopt=abstract
7. 43803 OI-LS-301; PUBMED-OI-7/26/2004
Characterization of a mitochondrion-like organelle in Cryptosporidium parvum
Putignani, L, Tait, A, Smith, HV, Horner, D, Tovar, J, Tetley, L, and Wastling, JM
Parasitology 2004. 129(Pt 1): 1-18
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15267107&dopt=abstract
8. 43804 OI-LS-301; SCIFINDER-OI-7/21/2004
Cryptosproridium parvum genomics: impact on research and control
Zhu, G and Abrahamsen, MS
World Class Parasites 2004. 8(Patogenic Enteric Protozoa): 153-163
9. 43805 OI-LS-301; PUBMED-OI-7/26/2004
Induction of a Novel Class of Diacylglycerol Acyltransferases and Triacylglycerol Accumulation in Mycobacterium tuberculosis as It Goes into a Dormancy-Like State in Culture
Daniel, J, Deb, C, Dubey, VS, Sirakova, TD, Abomoelak, B, Morbidoni, HR, and Kolattukudy, PE
J Bacteriol 2004. 186(15): 5017-30
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15262939&dopt=abstract
10. 43806 OI-LS-301; SCIFINDER-OI-7/21/2004
Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target
Roberts, Craig W, Roberts, Fiona, Henriquez, Fiona L, Akiyoshi, Donna, Samuel, Benjamin U, Richards, Thomas A, Milhous, Wilbur, Kyle, Dennis, McIntosh, Lee, Hill, George C, Chaudhuri, Minu, Tzipori, Saul, and McLeod, Rima
International Journal for Parasitology 2004. 34(3): 297-308
11. 43807 OI-LS-301; SCIFINDER-OI-7/21/2004
(E)- and (Z)-1,2,4-Triazolylchromanone oxime ethers as conformationally constrained antifungals
Emami, Saeed, Falahati, Mehraban, Banifatemi, Ali, Amanlou, Massoud, and Shafiee, Abbas
Bioorganic & Medicinal Chemistry 2004. 12(15): 3971-3976
12. 43808 OI-LS-301; PUBMED-OI-7/26/2004
BILN 2061: a major step toward new therapeutic strategies in hepatitis C
Asselah, T and Marcellin, P
J Hepatol 2004. 41(1): 178-81
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15246233&dopt=abstract
13. 43809 OI-LS-301; SCIFINDER-OI-7/21/2004
Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1)
Orchard, Michael G, Neuss, Judi C, Galley, Carl MS, Carr, Andrew, Porter, David W, Smith, Phillip, Scopes, David IC, Haydon, David, Vousden, Katherine, Stubberfield, Colin R, Young, Kate, and Page, Martin
Bioorganic & Medicinal Chemistry Letters 2004. 14(15): 3975-3978
14. 43810 OI-LS-301; SCIFINDER-OI-7/21/2004
Use of 1-phosphotidylinositol-4-phosphate 5-kinase (MSS4) from Candida or Aspergillus as an antifungal target and screening methods for MSS4 inhibitors((Oxford Glycosciences (UK) Ltd, UK)
Haydon, David John
PATENT: WO 2004053150 A1; ISSUE DATE: 20040624
APPLICATION: 2003; PP: 23 pp.
15. 43811 OI-LS-301; PUBMED-OI-7/26/2004
Synthesis and Antimicrobial Activity of New 2-[p-Substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles
Yildiz-Oren, I, Tekiner-Gulbas, B, Yalcin, I, Temiz-Arpaci, O, Aki-Sener, E, and Altanlar, N
Arch Pharm (Weinheim) 2004. 337(7): 402-10
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15237391&dopt=abstract
16. 43812 OI-LS-301; SCIFINDER-OI-7/21/2004
Preparation of pyrazole derivatives as antifungal agents((SSP Co., Ltd. Japan)
Konno, Fujiko, Nakazawa, Kyoko, Hirota, Hiroyuki, Ishida, Kazuya, Kaneko, Yasushi, and Okouchi, Hisako
PATENT: WO 2004033432 A1; ISSUE DATE: 20040422
APPLICATION: 2003; PP: 102 pp.
17. 43813 OI-LS-301; SCIFINDER-OI-7/21/2004
Design, synthesis and biological evaluation of some pyrazole derivatives as anti-inflammatory-antimicrobial agents
Bekhit, Adnan A and Abdel-Aziem, Tarek
Bioorganic & Medicinal Chemistry 2004. 12(8): 1935-1945
18. 43814 OI-LS-301; PUBMED-OI-7/26/2004
RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins
Kim, K, Trang, P, Umamoto, S, Hai, R, and Liu, F
Nucleic Acids Res 2004. 32(11): 3427-34
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15220469&dopt=abstract
19. 43815 OI-LS-301; WOS-OI-7/18/2004
Fungicidal effect of three new synthetic cationic peptides against Candida albicans
Nikawa, H, Fukushima, H, Makihira, S, Hamada, T, and Samaranayake, LP
ORAL DIS 2004. 10(4): 221-228
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000221977900006
20. 43816 OI-LS-301; WOS-OI-7/18/2004
DNA minor groove binders as potential antitumor and antimicrobial agents
Baraldi, PG, Bovero, A, Fruttarolo, F, Preti, D, Tabrizi, MA, Pavani, MG, and Romagnoli, R
MED RES REV 2004. 24(4): 475-528
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222199300004
21. 43817 OI-LS-301; WOS-OI-7/18/2004
Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis
Marino, S, Pawar, S, Fuller, CL, Reinhart, TA, Flynn, JL, and Kirschner, DE
J IMMUNOL 2004. 173(1): 494-506
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222170900063
22. 43818 OI-LS-301; SCIFINDER-OI-7/21/2004
Preparation of biguanide and dihydrotriazine derivatives for use in pharmaceutical compositions as antimicrobial agents((Jacobus Pharmaceutical Company, Inc. USA)
Jacobus, David P, Schiehser, Guy Alan, Shieh, Hong-Ming, Jensen, Norman P, and Terpinski, Jacek
PATENT: WO 2004048320 A1; ISSUE DATE: 20040610
APPLICATION: 2003; PP: 83 pp.
23. 43819 OI-LS-301; WOS-OI-7/18/2004
Characterization of polynucleotide kinase/phosphatase enzymes from mycobacteriophages omega and Cjw1 and vibriophage KVP40
Zhu, H, Yin, SM, and Shuman, S
J BIOL CHEM 2004. 279(25): 26358-26369
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222003000056
24. 43820 OI-LS-301; WOS-OI-7/18/2004
Characterization of Mycobacterium smegmatis expressing the Mycobacterium tuberculosis fatty acid synthase I (fas1) gene
Zimhony, O, Vilcheze, C, and Jacobs, WR
J BACTERIOL 2004. 186(13): 4051-4055
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222189500001
25. 43821 OI-LS-301; SCIFINDER-OI-7/21/2004
Antimycobacterial compounds ((USA))
Yatvin, Milton B and Pederson, Richard L
PATENT: US 20040127506 A1; ISSUE DATE: 20040701
APPLICATION: 2003-16446; PP: 9 pp., Cont. of U.S. Ser. No. 994,974.
26. 43822 OI-LS-301; SCIFINDER-OI-7/21/2004
Influence of lipophilicity on the antimycobacterial activity of the hydrochlorides of piperidinylethyl esters of ortho-substituted phenylcarbamic acids
Waisser, K, Drazkova, K, Cizmarik, J, and Kaustova, J
Scientia Pharmaceutica 2004. 72(1): 43-49
27. 43823 OI-LS-301; WOS-OI-7/18/2004
Decision analysis to evaluate proof-of-principle trial design for a new drug candidate
Viswanathan, V and Bayney, R
INTERFACES 2004. 34(3): 206-207
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222197900004
28. 43824 OI-LS-301; SCIFINDER-OI-7/21/2004
Synthesis of tetrahydro-2H-[1, 3, 5]thiadiazine-5-(4-pyridylcarboxamido)-2-thione with antitubercular activity
Sriram, D, Mallika, KJyothi, and Yogeeswari, P
Scientia Pharmaceutica 2004. 72(1): 35-41
29. 43825 OI-LS-301; SCIFINDER-OI-7/21/2004
Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives
Klimesova, Vera, Zahajska, Lenka, Waisser, Karel, Kaustova, Jarmila, and Mollmann, Ute
Farmaco 2004. 59(4): 279-288
30. 43826 OI-LS-301; WOS-OI-7/18/2004
Comparative genomic assessment of novel broad-spectrum targets for antibacterial drugs
White, TA and Kell, DB
COMP FUNCT GENOM 2004. 5(4): 304-327
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222231600001
31. 43827 OI-LS-301; SCIFINDER-OI-7/21/2004
Preparation of pyrrole derivatives as antimycobacterial compounds((Lupin Limited, India)
Arora, Sudershan Kumar, Sinha, Neelima, Jain, Sanjay, Upadhayaya, Ram Shankar, Jana, Gourhari, Ajay, Shankar, and Sinha, Rakesh Kumar
PATENT: WO 2004026828 A1; ISSUE DATE: 20040401
APPLICATION: 2002; PP: 66 pp.
32. 43828 OI-LS-301; SCIFINDER-OI-7/21/2004
Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides
Waisser, Karel, Drazkova, Katerina, Kunes, Jiri, Klimesova, Vera, and Kaustova, Jarmila
Farmaco 2004. 59(8): 615-625
33. 43829 OI-LS-301; WOS-OI-7/25/2004
The Arden house Conference on Tuberculosis, revisited: Perspectives for tuberculosis elimination in the United States
Jereb, J, Albalak, R, and Castro, K
SEM RESP CRIT CARE M 2004. 25(3): 255-269
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222336800003
34. 43830 OI-LS-301; WOS-OI-7/25/2004
Mycobacterial infections caused by nontuberculous mycobacteria
Heifets, L
SEM RESP CRIT CARE M 2004. 25(3): 283-295
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222336800005
35. 43831 OI-LS-301; WOS-OI-7/25/2004
Antimicrobial therapy of tuberculosis: Justification for currently recommended treatment regimens
Mitchison, DA
SEM RESP CRIT CARE M 2004. 25(3): 307-315
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222336800007
36. 43832 OI-LS-301; WOS-OI-7/25/2004
Tuberculosis and HIV/AIDS: Epidemiological and clinical aspects (World perspective)
Bock, N and Reichman, LB
SEM RESP CRIT CARE M 2004. 25(3): 337-344
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222336800009
37. 43833 OI-LS-301; SCIFINDER-OI-7/21/2004
Synthesis and antiviral activity of monofluorinated cyclopropanoid nucleosides
Rosen, Thomas C, De Clercq, Erik, Balzarini, Jan, and Haufe, Guenter
Organic & Biomolecular Chemistry 2004. 2(2): 229-237
38. 43834 OI-LS-301; WOS-OI-7/25/2004
Synthesis and antimycobacterial activity of some beta-carboline alkaloids
Begum, S, Hassan, SI, and Siddiqui, BS
NAT PROD RES 2004. 18(4): 341-347
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222182400010
39. 43835 OI-LS-301; SCIFINDER-OI-7/21/2004
The Synthesis and Antiviral Activity of Glycyrrhizic Acid Conjugates with a-D-Glucosamine and Some Glycosylamines
Kondratenko, RM, Baltina, LA, Mustafina, SR, Vasil'eva, EV, Pompei, R, Deidda, D, Plyasunova, OA, Pokrovskii, AG, and Tolstikov, GA
Russian Journal of Bioorganic Chemistry (Translation of Bioorganicheskaya Khimiya) 2004. 30(3): 275-282
40. 43836 OI-LS-301; WOS-OI-7/25/2004
Endogenous polyamine levels in macrophages is sufficient to support growth of Toxoplasma gondii
Seabra, SH, DaMatta, RA, de, Mello FG, and de, Souza W
J PARASITOL 2004. 90(3): 455-460
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222292200003
41. 43837 OI-LS-301; SCIFINDER-OI-7/21/2004
Antiviral activity of natural and synthetic brassinosteroids
Wachsman, Monica B, Ramirez, Javier A, Talarico, Laura B, Galagovsky, Lydia R, and Coto, Celia E
Current Medicinal Chemistry: Anti-Infective Agents 2004 . 3(2): 163-179
42. 43838 OI-LS-301; WOS-OI-7/25/2004
Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice
Mitchell, SM, Zajac, AM, Davis, WL, and Lindsay, DS
J PARASITOL 2004. 90(3): 639-642
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222292200032
43. 43839 OI-LS-301; SCIFINDER-OI-7/21/2004
Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay
Friedrichs, Claudia, Neyts, Johan, Gaspar, Gabor, De Clercq, Erik, and Wutzler, Peter
Antiviral Research 2004. 62(3): 121-123
44. 43840 OI-LS-301; WOS-OI-7/25/2004
Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs
Melen, K, Fagerlund, R, Nyqvist, M, Keskinen, P, and Julkunen, I
J MED VIROL 2004. 73(4): 536-547
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222317200007
45. 43841 OI-LS-301; SCIFINDER-OI-7/21/2004
Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors
Chern, Jyh-Haur, Shia, Kak-Shan, Hsu, Tsu-An, Tai, Chia-Liang, Lee, Chung-Chi, Lee, Yen-Chun, Chang, Chih-Shiang, Tseng, Sung-Nien, and Shih, Shin-Ru
Bioorganic & Medicinal Chemistry Letters 2004. 14(10): 2519-2525
46. 43842 OI-LS-301; WOS-OI-7/25/2004
YM-215343, a novel antifungal compound from Phoma sp QN04621
Shibazaki, M, Taniguchi, M, Yokoi, T, Nagai, K, Watanabe, M, Suzuki, K, and Yamamoto, T
J ANTIBIOT 2004. 57(6): 379-382
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222339800003
47. 43843 OI-LS-301; SCIFINDER-OI-7/21/2004
Design and synthesis of DNA-intercalating 9-fluoren-b-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents
Alcaro, S, Arena, A, Neri, S, Ottana, R, Ortuso, F, Pavone, B, and Vigorita, MG
Bioorganic & Medicinal Chemistry 2004. 12(7): 1781-1791
48. 43844 OI-LS-301; WOS-OI-7/25/2004
Mycobactetium avium subsp paratuberculosis fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge with host integrins
Secott, TE, Lin, TL, and Wu, CC
INFECT IMMUN 2004. 72(7): 3724-3732
HYPERLINK: http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222282800004
49. 43845 OI-LS-301; SCIFINDER-OI-7/21/2004
Synthesis and Antiviral Evaluation of Some 3'-Fluoro Bicyclic Nucleoside Analogues
McGuigan, Christopher, Carangio, Antonella, Snoeck, Robert, Andrei, Graciela, De Clercq, Erik, and Balzarini, Jan
Nucleosides, Nucleotides & Nucleic Acids 2004. 23(1 & 2): 1-5
50. 43846 OI-LS-301; SCIFINDER-OI-7/21/2004
Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans
Marchetti, Magda, Trybala, Edward, Superti, Fabiana, Johansson, Maria, and Bergstrom, Tomas
Virology 2004. 318(1): 405-413